<DOC>
	<DOC>NCT00266721</DOC>
	<brief_summary>The hypothesis of this study is that the administration of pancrelipase with meals will benefit symptoms of post-prandial bloating, pain and eructation.</brief_summary>
	<brief_title>Efficacy of Pancrelipase on Postprandial Belching and Bloating.</brief_title>
	<detailed_description>Subjects will complete a double-blind crossover study in which, for one week periods, they will receive two pancrelipase tablets with each of the three major meals or a similarly administered identical placebo. Three times daily, subjects will rate the severity of belching, epigastric discomfort, epigastric fullness, bloating, and nausea.</detailed_description>
	<mesh_term>Eructation</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Subjects will have either bothersome upper abdominal discomfort, bloating (feeling of abdominal distention) or belching following meals for at least 12 month's duration. Subjects must have had a normal upper gastrointestinal endoscopy and/or upper GI series during the preceding three years. Individuals with a history suggestive of organic disease such as recent weight loss, nausea, vomiting, GERD, recent changes in bowel habits will be excluded from the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2000</verification_date>
	<keyword>Pancrelipase</keyword>
	<keyword>Abdominal bloating</keyword>
	<keyword>Abdominal pain</keyword>
	<keyword>Eructation</keyword>
</DOC>